Post by
1mattman on Nov 18, 2020 8:45am
CEO Interview from yesterday
Great explanations. Time will tell with this company.
https://www.businessofcannabis.ca/2020/11/17/how-a-cannabis-derived-therapy-may-help-covid-patients/
Lots going on here.
Comment by
Kingofstockst on Nov 18, 2020 1:33pm
Yup great interview, this ards is a great bonus on top of core projects, ards alone and not relying on covid19 os $500mil he said wow good things coming
Comment by
Davesnothere on Nov 18, 2020 5:20pm
WOW. Very encouraging interview. Thanks for posting link. I have been accumulating TBP for many years. That also means that my cost is relatively high. 70 cents. Now, obviously, there is good reason to be hopeful. Too bad Rosenthal did not ask about potential revenue from QIXLEEF , looks like Guy would have offered an estimate.
Comment by
NSPfacts on Nov 19, 2020 12:34am
This post has been removed in accordance with Community Policy
Comment by
Davesnothere on Dec 07, 2020 10:24am
Very funny how this request for QIXLEEF potential revenue was answered so QUIXLEE !!!! Based on a conservative market penetration and patient-based model, Tetra estimates potential net sales of US$675 million by 2027. Thank you Guy, we have faith !